Prosecution Insights
Prosecution Insights
43 pending office actions • 33 art units • 39 examiners • 0 of 43 (0%) have an AI response strategy ready • 57 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 43 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 43 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 22 (51%) |
| §102 only | 3 (7%) |
| §112 only | 3 (7%) |
| No statute on record | 15 (35%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOTFREDSON, GAREN | 2 | 40.0% | +29.1% |
| SCHMITT, MICHAEL J | 2 | 56.6% | +21.7% |
| MOLOYE, TITILAYO | 2 | 63.4% | +47.1% |
| HIBSHMAN, SARAH GRACE | 2 | 40.9% | +46.3% |
| BRAZIN, JACQUELINE | 1 | 66.3% | +53.5% |
| COHEN, MICHAEL P | 1 | 58.5% | +27.6% |
| GILLIGAN, CHRISTOPHER L | 1 | 57.3% | +39.7% |
| DAHLIN, HEATHER RAQUEL | 1 | 46.5% | +48.9% |
| HOAG, MITCHELL BRAIN | 1 | 70.0% | +14.1% |
| LIU, BENJAMIN T | 1 | 74.4% | +12.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18516195 | PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORS | GOTFREDSON, GAREN | 112d overdue |
| 17822245 | TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 | MOLOYE, TITILAYO | 77d overdue |
| 17768145 | ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS | HIBSHMAN, SARAH GRACE | 70d overdue |
| 17845461 | COMPOSITION AND METHODS FOR CULTURING RETINAL PROGENITOR CELLS | MOLOYE, TITILAYO | 36d overdue |
| 17768166 | TARGETED BIFUNCTIONAL DEGRADERS | GOTFREDSON, GAREN | 30d overdue |
| 18557008 | ON-CHIP SPECTROMETER WITH TUNABLE PHOTODETECTION LAYER | LIU, BENJAMIN T | 26d overdue |
| 17654984 | ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS | HIBSHMAN, SARAH GRACE | 23d overdue |
| 18790607 | Protein Capture Membrane and Method of Use Thereof | BRAZIN, JACQUELINE | 9d overdue |
| Art Unit | Apps |
|---|---|
| 1629 | 4 |
| 1612 | 2 |
| 1619 | 2 |
| 1625 | 2 |
| 1627 | 2 |
| 1632 | 2 |
| 1675 | 2 |
| 1693 | 2 |
| 1798 | 1 |
| 3683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18790607 | Protein Capture Membrane and Method of Use Thereof | BRAZIN, JACQUELINE | 1798 | §103 | Non-Final OA | 9d overdue | Pending | Jul 31, 2024 |
| 18674209 | POLY(AMINE-CO-ESTER) POLYMERS AND POLYPLEXES WITH MODIFIED END GROUPS AND METHODS OF USE THEREOF | COHEN, MICHAEL P | 1612 | Other | Non-Final OA | 16d | Pending | May 24, 2024 |
| 18660594 | MACHINE LEARNING SYSTEM AND METHODS FOR INCREASING APPOINTMENT COMPLIANCE | GILLIGAN, CHRISTOPHER L | 3683 | §103 | Final Rejection | 23d | Pending | May 10, 2024 |
| 18623722 | EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE | DAHLIN, HEATHER RAQUEL | 1629 | §103 | Non-Final OA | 53d | Pending | Apr 01, 2024 |
| 18616372 | ENDOBRONCHIAL BLOCKER SYSTEM AND APPARATUS | HOAG, MITCHELL BRAIN | 3771 | §103 | Final Rejection | 23d | Pending | Mar 26, 2024 |
| 18516195 | PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORS | GOTFREDSON, GAREN | 1619 | §103 | Non-Final OA | 112d overdue | Pending | Nov 21, 2023 |
| 18557008 | ON-CHIP SPECTROMETER WITH TUNABLE PHOTODETECTION LAYER | LIU, BENJAMIN T | 2893 | §103 | Non-Final OA | 26d overdue | Pending | Oct 24, 2023 |
| 18555112 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER | COUGHLIN, MATTHEW P | 1626 | §102 | Non-Final OA | 13d | Pending | Oct 12, 2023 |
| 18043436 | N-Linked Glycosylation Inhibitors and Methods of Using Same | WEDDINGTON, KEVIN E | 1629 | §102 | Non-Final OA | 34d | Pending | Sep 22, 2023 |
| 18277505 | MULTIMODE SUPERCONDUCTING CAVITY RESONATORS | HOSSAIN, MOAZZAM | 2898 | §103 | Non-Final OA | 15d | Pending | Aug 16, 2023 |
| 18446296 | Bi-functional Molecules To Degrade Circulating Proteins | SCHMITT, MICHAEL J | 1629 | Other | Non-Final OA | 14d | Pending | Aug 08, 2023 |
| 18357810 | MULTIFUNCTIONAL pO2/pH-SENSITIVE THERANOSTIC LIPOSOME NANOCARRIERS AND METHODS OF USING SAME | ROSENTHAL, ANDREW S | 1613 | §103 | Non-Final OA | 3d overdue | Pending | Jul 24, 2023 |
| 18349851 | FLUORESCENT COMPOUND COMPRISING A FLUOROPHORE CONJUGATED TO A pH-TRIGGERED POLYPEPTIDE | DICKINSON, PAUL W | 1618 | Other | Non-Final OA | 32d overdue | Pending | Jul 10, 2023 |
| 18266917 | USE OF MGLUR5 ANTAGONISTS FOR TREATING GAMBLING DISORDER | ROZOF, TIMOTHY R | 1625 | §103 | Non-Final OA | 49d overdue | Pending | Jun 13, 2023 |
| 18314688 | IMMUNOTHERAPY OF SKIN CANCER USING MPLA-LOADED HPG NANOPARTICLES | RONEY, CELESTE A | 1612 | Other | Final Rejection | 22d | Pending | May 09, 2023 |
| 18250530 | Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same | HASTINGS, ALISON AZAR | 1627 | §102 | Non-Final OA | 66d overdue | Pending | Apr 25, 2023 |
| 18300984 | Compositions and Methods of Treating or Preventing Fibrotic Lung Diseases | PIHONAK, SARAH | 1627 | Other | Final Rejection | 161d overdue | Pending | Apr 14, 2023 |
| 18133900 | DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS | JUEDES, AMY E | 1644 | Other | Non-Final OA | 84d overdue | Pending | Apr 12, 2023 |
| 18043534 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS | LANDSMAN, ROBERT S | 1647 | §112 | Non-Final OA | 84d overdue | Pending | Feb 28, 2023 |
| 18042993 | Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting | KIM, SEONG JONG | 1621 | §103 | Non-Final OA | 4d overdue | Pending | Feb 24, 2023 |
| 18005444 | COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC | DEVI, SARVAMANGALA | 1645 | — | Non-Final OA | 4d overdue | Pending | Jan 13, 2023 |
| 18003125 | Compositions and Methods for Selective Detection and/or Inhibition of Bacterial Pathogens in Microbial Communities | BREEN, KIMBERLY CATHERINE | 1657 | §103 | Final Rejection | 10d overdue | Pending | Dec 22, 2022 |
| 18002710 | PanK Modulators and Methods Using Same | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | Other | Non-Final OA | 40d | Pending | Dec 21, 2022 |
| 18002477 | Methods of Treating, Ameliorating, Shortening Duration, and/or Reversing Symptoms and/or Complications of a Coronavirus Infection | RZECZYCKI, PHILLIP MATTHEW | 1625 | §103 | Final Rejection | 29d | Pending | Dec 19, 2022 |
| 17999324 | AN INTEGRATED DIELECTROPHORESIS-TRAPPING AND NANOWELL TRANSFER APPROACH TO ENABLE DOUBLE-SUB-POISSON SINGLE-CELL RNA-SEQUENCING | CHUNDURU, SURYAPRABHA | 1681 | §103 | Non-Final OA | 9d overdue | Pending | Nov 18, 2022 |
| 17822245 | TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 | MOLOYE, TITILAYO | 1632 | §103 | Non-Final OA | 77d overdue | Pending | Aug 25, 2022 |
| 17813395 | INTEGRATED CIRCUIT WITH TOPOLOGICAL SEMIMETAL INTERCONNECTS | DUMBRIS, SETH M | 1784 | §103 | Final Rejection | 34d | Pending | Jul 19, 2022 |
| 17845461 | COMPOSITION AND METHODS FOR CULTURING RETINAL PROGENITOR CELLS | MOLOYE, TITILAYO | 1632 | §103 | Final Rejection | 36d overdue | Pending | Jun 21, 2022 |
| 17782338 | A T cell-based immunotherapy for central nervous system viral infections and tumors | ALSOMAIRY, SARAH ABDOALATIF | 1646 | Other | Final Rejection | 15d | Pending | Jun 03, 2022 |
| 17756212 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING ISCHEMIA-REPERFUSION INJURY AND/OR LUNG INJURY | SCHMITT, MICHAEL J | 1629 | Other | Non-Final OA | 20d | Pending | May 19, 2022 |
| 17769642 | COMPOSITIONS AND METHODS FOR INHIBITION OF CELL-PENETRATING ANTIBODIES | PATTERSON, SARAH COOPER | 1675 | §112 | Non-Final OA | 11d overdue | Pending | Apr 15, 2022 |
| 17768166 | TARGETED BIFUNCTIONAL DEGRADERS | GOTFREDSON, GAREN | 1619 | §103 | Non-Final OA | 30d overdue | Pending | Apr 11, 2022 |
| 17768145 | ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS | HIBSHMAN, SARAH GRACE | 1693 | Other | Non-Final OA | 70d overdue | Pending | Apr 11, 2022 |
| 17764804 | DETERMINISTIC BARCODING FOR SPATIAL OMICS SEQUENCING | FLINDERS, JEREMY C | 1684 | Other | Final Rejection | 28d overdue | Pending | Mar 29, 2022 |
| 17654984 | ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS | HIBSHMAN, SARAH GRACE | 1693 | Other | Non-Final OA | 23d overdue | Pending | Mar 15, 2022 |
| 17641516 | NANOPARTICLES FOR SELECTIVE TISSUE OR CELLULAR UPTAKE | LAZARO, DOMINIC | 1611 | §103 | Final Rejection | 30d overdue | Pending | Mar 09, 2022 |
| 17620182 | IN-SITU AND SELECTIVE AREA ETCHING OF SURFACES OR LAYERS, AND HIGH-SPEED GROWTH OF GALLIUM NITRIDE, BY ORGANOMETALLIC CHLORINE PRECURSORS | BRATLAND JR, KENNETH A | 1714 | §103 | Final Rejection | 92d overdue | Pending | Dec 17, 2021 |
| 17510981 | METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS | SCHUBERG, LAURA J | 1631 | Other | Non-Final OA | 44d overdue | Pending | Oct 26, 2021 |
| 17289882 | Quantitative Algorithm for Endometriosis | LIU, GUOZHEN | 1686 | §103 | Non-Final OA | 13d | Pending | Apr 29, 2021 |
| 17283315 | Selective Binding and Aggregation of Human Keratin in the Skin Barrier Using Human Filaggrin Subdomains SD67 and SD150 | DABKOWSKI, ERINNE R | 1654 | §112 | Final Rejection | 57d | Pending | Apr 07, 2021 |
| 17272124 | COMPOSITIONS AND METHODS OF USING CELL-PENETRATING ANTIBODIES IN COMBINATION WITH IMMUNE CHECKPOINT MODULATORS | ESSEX, LAURA ANN | 1675 | §103 | Final Rejection | 45d overdue | Pending | Feb 26, 2021 |
| 17160050 | TARGETING GENE AMPLIFICATION IN CANCER USING TRIPLEX FORMATION AS A THERAPEUTIC STRATEGY | HUDSON, AMY ROSE | 1636 | Other | Final Rejection | 97d overdue | Pending | Jan 27, 2021 |
| 15548197 | INTEGRATED PAINLESS BONE MARROW BIOPSY DEVICE | CATINA, MICHAEL ANTHONY | 3791 | §103 | Final Rejection | 30d | Pending | Aug 02, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial